Current Report Filing (8-k)
October 04 2017 - 5:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
|
September
18, 2017
|
GREY CLOAK TECH INC.
(Exact name of registrant as specified in its
charter)
Nevada
(State or other
jurisdiction of incorporation)
|
|
333-202542
(Commission
File Number)
|
|
47-2594704
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
10300 W. Charleston
Las Vegas, NV 89135
(Address of principal executive
offices) (zip code)
|
|
|
|
|
|
(702) 201-6450
(Registrant’s telephone number, including
area code)
|
|
|
|
|
|
|
|
|
|
|
(Former name or former address, if changed since last report.)
|
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
[_] Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 8 – Other Events
On September 18, 2017 we
executed a Letter of Intent with Eqova Life Sciences, a medically-focused CBD company. The Letter of Intent is non-binding, but
the parties expect to consummate the transaction as soon as reasonably practicable.
A press release issued
on September 19, 2017 announcing the Letter of Intent is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.
Section 9 – Financial Statements and
Exhibits
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
Grey Cloak Tech Inc.
|
|
|
|
|
Dated:
October 4, 2017
|
/s/ William Bossung
|
|
By: William Bossung
|
|
Its: Chief Financial Officer and Secretary
|
EXHIBIT INDEX